177Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial

European Urology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles